Translational Development Acquisition Corp.

Translational Development Acquisition Corp. (warrants: TDACW) is a blank-check company focused on the life sciences and healthcare sector, targeting businesses at the intersection of scientific research and commercial development. The company filed a Form 425 communication with the SEC on June 15, 2026, accession number 0001193125-26-270239, indicating active deal-related disclosure activity consistent with a business combination in progress. Form 425 filings are required prospectus communications made in connection with proposed mergers or acquisitions involving registered securities. The TDACW ticker represents the warrant class associated with the SPAC unit structure. Visit SpacDesk and create a free account to access the full filing history, deal timeline, and real-time data for Translational Development Acquisition Corp.